Person:
Li, David

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Li

First Name

David

Name

Li, David

Filters

20181

Settings

Author's Publications: search.filters.isAuthorOfPublication.5b7cee2a-4cb9-4835-a428-401592b3661d

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Publication
    Development and Pilot-Testing of the Alopecia Areata Assessment Tool (ALTO)
    (Public Library of Science (PLoS), 2018-06-06) Li, David; Huang, Kathie; Xia, Fan Di; Joyce, Cara; Scott, Deborah; Qureshi, Abrar A.; Mostaghimi, Arash
    Background Alopecia areata (AA) is an autoimmune disease characterized by non-scarring hair loss. The lack of a definitive biomarker or formal diagnostic criteria for AA limits our ability to define the epidemiology of the disease. In this study, we developed and tested the Alopecia Areata Assessment Tool (ALTO) in an academic medical center to validate the ability of this questionnaire in identifying AA cases. Methods The ALTO is a novel, self-administered questionnaire consisting of 8 closed-ended questions derived by the Delphi method. This prospective pilot study was administered during a 1-year period in outpatient dermatology clinics. Eligible patients (18 years or older with chief concern of hair loss) were recruited consecutively. No patients declined to participate. The patient’s hair loss diagnosis was determined by a board-certified dermatologist. Nine scoring algorithms were created and used to evaluate the accuracy of the ALTO in identifying AA. Results 239 patients (59 AA cases and 180 non-AA cases) completed the ALTO and were included for analysis. Algorithm 5 demonstrated the highest sensitivity (89.8%) while algorithm 3 demonstrated the highest specificity (97.8%). Select questions were also effective in clarifying disease phenotype. Conclusion In this study. we have successfully demonstrated that ALTO is a simple tool capable of discriminating AA from other types of hair loss. The ALTO may be useful to identify individuals with AA within large populations.